Thorne HealthTech Past Earnings Performance

Past criteria checks 4/6

Thorne HealthTech has been growing earnings at an average annual rate of 121.9%, while the Personal Products industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 25.5% per year. Thorne HealthTech's return on equity is 12.7%, and it has net margins of 7.9%.

Key information

121.9%

Earnings growth rate

159.7%

EPS growth rate

Personal Products Industry Growth8.7%
Revenue growth rate25.5%
Return on equity12.7%
Net Margin7.9%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Thorne HealthTech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:F7G Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 23258201097
31 Mar 23240101117
31 Dec 22229161027
30 Sep 2221661027
30 Jun 2220631038
31 Mar 221949867
31 Dec 211844796
30 Sep 21172-1745
30 Jun 21162-1634
31 Mar 21150-3614
31 Dec 20138-3604
31 Dec 19103-22554

Quality Earnings: F7G has a high level of non-cash earnings.

Growing Profit Margin: F7G's current net profit margins (7.9%) are higher than last year (1.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: F7G's earnings have grown significantly by 121.9% per year over the past 5 years.

Accelerating Growth: F7G's earnings growth over the past year (548.7%) exceeds its 5-year average (121.9% per year).

Earnings vs Industry: F7G earnings growth over the past year (548.7%) exceeded the Personal Products industry 9.6%.


Return on Equity

High ROE: F7G's Return on Equity (12.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.